The purpose of this paper was to compare levels of α-synuclein and neurofilament light chain (NFL) in case-matched K2EDTA and K3EDTA plasma specimens and between plasma from patients with early or advanced-stage Parkinson’s disease and healthy controls that were obtained by centrifugation at room temperature or 4°C.
Assessing Plasma Levels of α-Synuclein and Neurofilament Light Chain by Different Blood Preparation Methods.
Chang KH, Liu KC, Lai CS, Yang SY, Chen CM
Purpose
Conclusion
Levels of α-synuclein and NFL were comparable and very strongly correlated between case-matched K2EDTA and K3EDTA plasma, but levels of α-synuclein were significantly higher when plasma was separated by centrifugation at room temperature rather than at 4°C. When plasma was obtained by room temperature centrifugation, levels of α-synuclein were higher in plasma from early and advanced-stage Parkinson’s disease patients than in plasma from healthy controls but the difference was not significant when plasma was obtained by centrifugation at 4°C. In contrast, NFL levels were comparable among plasma obtained by centrifugation at 4°C or room temperature. Overall, NFL levels were higher in plasma from patients with Parkinson’s disease than healthy controls, although differences were only significant for advanced-stage Parkinson’s disease patients when centrifugation occurred at room temperature, and for early-stage Parkinson’s disease patients when centrifugation occurred at 4°C. Based on area under the curve analysis, only α-synuclein quantified in plasma obtained by room temperature centrifugation adequately separated patients with Parkinson’s disease from healthy controls.
Studies (1)
Purpose
The purpose of this study was to compare levels of α-synuclein and neurofilament light chain (NFL) in case-matched K2EDTA and K3EDTA plasma specimens and between plasma from patients with early or advanced-stage Parkinson’s disease and healthy controls that were obtained by centrifugation at room temperature or 4°C. Blood was obtained from 42 patients with Parkinson’s disease and 40 age- and gender-matched heathy controls into K2EDTA tubes, unless otherwise specified. Plasma was obtained by centrifugation at 1,500–2,500 g for 15 min within 1 h of venipuncture. To investigate potential effects of different potassium salts of EDTA on measured levels of α-synuclein and NFL, blood was collected from eight patients with Parkinson’s disease and seven of the age- and gender-matched heathy controls into both K2EDTA and K3EDTA tubes. To test the effects of processing temperature, one K2EDTA tube from each of the 82 patients was centrifuged at 4°C and the other at room temperature. Levels of α-synuclein and NFL were measured in duplicate with an immunomagnetic reduction (IMR) assay on a XacPro-S361. Hemoglobin was quantified spectrophotometrically.
Summary of Findings
Levels of α-synuclein and NFL were comparable and very strongly correlated between case-matched K2EDTA and K3EDTA plasma (R2 = 0.918, P < 0.001 and R2 = 0.836, P < 0.001, respectively). Levels of α-synuclein were higher in plasma from patients with Parkinson’s disease than in healthy controls regardless of whether anticoagulation was with K2EDTA (P=0.016) or K3EDTA (P=0.001); however, levels of NFL did not differ between plasma from patients with Parkinson’s disease and healthy controls in the anticoagulant type study. Levels of α-synuclein were significantly higher in plasma isolated by centrifugation at room temperature than at 4°C (181.23 ± 196.31 fg/mL versus 101.57 ± 43.43 fg/mL, P<0.0001); α-synuclein levels were not correlated between specimens centrifuged at different temperatures (R2=0.007, P=0.444)., Levels of α-synuclein were higher in plasma from Parkinson’s patients than in healthy controls when plasma was obtained by room temperature centrifugation (256.6±50.2 fg/ml and 102.1 ± 0.66 fg/ml, P < 0.001), but the difference was not significant when plasma was obtained by centrifugation at 4°C (111.1 ± 48.69 fg/mL versus 91.59 ±35 fg/mL, P=0.085). Importantly, the observed difference in α-synuclein levels between patients with Parkinson’s disease and healthy controls when plasma was isolated by room temperature centrifugation remained significant after correction for hemoglobin (P<0.001). In contrast, NFL levels were comparable and very strongly correlated between plasma obtained by centrifugation at 4°C and room temperature (R2=0.836, P<0.001); and, NFL levels were higher in plasma from patients with Parkinson’s disease than healthy controls under both centrifugation temperatures (room temperature: 16.47 ± 9.96 pg/ml versus 11.24 ± 4.06 pg/ml, P=0.006 and 4°C: 13.92 ± 8.31 pg/ml versus 9.84 ± 4.81 pg/ml, P = 0.017). Based on area under the curve analysis, only α-synuclein quantified in plasma obtained by room temperature centrifugation adequately separated patients with Parkinson’s disease from healthy controls. Further, levels of α-synuclein were higher in plasma of both early and advanced-stage Parkinson’s disease patients than in healthy controls when centrifugation was at room temperature (P<0.0001, both), while levels did not differ significantly when centrifugation occurred at 4°C. NFL levels were higher in plasma from advanced-stage (but not early stage) Parkinson’s disease patients than healthy controls when obtained by room temperature centrifugation (P=0.007) and in early-stage (but not advanced stage) patients than healthy controls when centrifuged at 4°C (P=0.028).
Biospecimens
FluidBloodFluidPlasmaPreservation Types
FrozenDiagnoses
NormalParkinson's DiseasePlatforms
ProteinImmunoassayProteinSpectrophotometryPre-analytical Factors
Classification Pre-Analytical Factor Value(s) Preaquisition Diagnosis/ patient condition Advanced-stage Parkinson's diseaseEarly-stage Parkinson's diseaseHealthy controlBiospecimen Acquisition Anticoagulant Multiple forms evaluatedPotassium EDTABiospecimen Aliquots and Components Centrifugation Multiple temperatures compared